Please provide your email address to receive an email when new articles are posted on . Most participants achieved IGF-1 control and reduced acromegaly symptoms at 1 year with CAM2029. Improvements in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback